MIF, considered the first active cytokine discovered (37), has been extensively studied in the context of immune activation and the inflammatory response, as well as in tumor biology, where it has been shown to drive cancer cell proliferation and the generation of a tumor-promoting immune microenvironment (38). Here, MIF is linked to cancer.